AI assistant
Sending…
Transgene — Share Issue/Capital Change 2022
Jul 7, 2022
1715_rns_2022-07-07_54353f25-b828-4606-8a9d-72c84161b30e.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
PRESS RELEASE
Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of June 30, 2022
Strasbourg, July 07, 2022 – 06:00 pm CET
Under the liquidity contract entrusted by Transgene to Natixis Oddo BHF SCA, as of June 30, 2022, the following resources were managed through the liquidity account:
-
- 230,257 shares,
-
- € 227,533.00.
In the first half of 2022, a total of:
| Purchases | 451,259 shares |
€ 1,036,761 | 747 market transactions |
|---|---|---|---|
| Sales | 397,502 shares |
€ 929,416 | 687 market transactions |
It is recalled that
-
- as of December 31, 2021, the following resources were managed through the liquidity account:
- 176,500 shares
- € 334,853.00
-
- when the liquidity program was initially established in 2016, the following resources were made available:
- Cash balance of the liquidity contract: € 500,000.00
-
- at the time the liquidity program was transferred to Natixis Oddo BHF SCA on January 2, 2020, the resources managed through the liquidity account consisted of:
- 164,183 shares
- € 246,158.00
Contacts
Transgene: Lucie Larguier Director Corporate Communications & IR +33 (0)3 88 27 91 04 [email protected]
More from Transgene
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 26
Declaration of Voting Results & Voting Rights Announcements
2026
May 22
Declaration of Voting Results & Voting Rights Announcements
2026
May 22
AGM Information
2026
May 4
Report Publication Announcement
2026
May 4
Earnings Release
2026
Apr 29
Earnings Release
2026
Apr 29
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Apr 13